88 related articles for article (PubMed ID: 3816105)
1. Evaluation of three dosage-prediction methods for initial in-hospital stabilization of warfarin therapy.
Carter BL; Taylor JW; Becker A
Clin Pharm; 1987 Jan; 6(1):37-45. PubMed ID: 3816105
[TBL] [Abstract][Full Text] [Related]
2. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response.
Sawyer WT; Poe TE; Canaday BR; Weiner JS; Williams DM; Webb CE; Ellison MJ
Clin Pharm; 1985; 4(4):440-6. PubMed ID: 3899472
[TBL] [Abstract][Full Text] [Related]
3. Warfarin dosage predictions assisted by the analog computer.
Carter BL; Barr W; Rock W; Taylor JW
Ther Drug Monit; 1988; 10(1):69-73. PubMed ID: 3376184
[TBL] [Abstract][Full Text] [Related]
4. Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response.
Lee C; Coleman RW; Mungall DR
Clin Pharm; 1987 May; 6(5):406-12. PubMed ID: 3665392
[TBL] [Abstract][Full Text] [Related]
5. Predicting warfarin maintenance dosage based on initial response.
Miller DR; Brown MA
Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
[TBL] [Abstract][Full Text] [Related]
6. The incidence, magnitude, and time course of the amiodarone-warfarin interaction.
Kerin NZ; Blevins RD; Goldman L; Faitel K; Rubenfire M
Arch Intern Med; 1988 Aug; 148(8):1779-81. PubMed ID: 3401099
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy.
Ellis RF; Stephens MA; Sharp GB
Am J Hosp Pharm; 1992 Feb; 49(2):387-94. PubMed ID: 1554003
[TBL] [Abstract][Full Text] [Related]
8. Nomogram for dosing warfarin at steady state.
Fredriks DA; Coleman RW
Clin Pharm; 1991 Dec; 10(12):923-7. PubMed ID: 1773579
[TBL] [Abstract][Full Text] [Related]
9. The influence of heparin on the prothrombin time.
Schultz NJ; Slaker RA; Rosborough TK
Pharmacotherapy; 1991; 11(4):312-6. PubMed ID: 1923913
[TBL] [Abstract][Full Text] [Related]
10. The negative impact of biological variation in the effect and clearance of warfarin on methods for prediction of dose requirements.
Weiss P; Halkin H; Almog S
Thromb Haemost; 1986 Dec; 56(3):371-5. PubMed ID: 3563968
[TBL] [Abstract][Full Text] [Related]
11. Single-dose fluconazole for vulvovaginal candidiasis: impact on prothrombin time in women taking warfarin.
Turrentine MA
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):310-3. PubMed ID: 16449117
[TBL] [Abstract][Full Text] [Related]
12. Effect of influenza vaccine in patients receiving long-term warfarin therapy.
Weibert RT; Lorentz SM; Norcross WA; Klauber MR; Jagger PI
Clin Pharm; 1986 Jun; 5(6):499-503. PubMed ID: 3720216
[TBL] [Abstract][Full Text] [Related]
13. Outpatient management of warfarin therapy: comparison of computer-predicted dosage adjustment to skilled professional care.
White RH; Mungall D
Ther Drug Monit; 1991 Jan; 13(1):46-50. PubMed ID: 2057991
[TBL] [Abstract][Full Text] [Related]
14. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
15. Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium.
Crussell-Porter LL; Rindone JP; Ford MA; Jaskar DW
Arch Intern Med; 1993 Jan; 153(1):102-4. PubMed ID: 8422191
[TBL] [Abstract][Full Text] [Related]
16. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
17. Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room.
Habib G; Nashashibi M; Khateeb A; Goichman S; Kogan A
Eur J Intern Med; 2008 Mar; 19(2):129-34. PubMed ID: 18249309
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.
Anderson DR; Harrison L; Hirsh J
Arch Intern Med; 1993 Jun; 153(12):1441-7. PubMed ID: 8512435
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between prothrombin time international normalized ratio and thrombo test (%)].
Numata Y; Ogata Y; Arao K; Mizumasa Y; Wakita T; Haruguchi H; Araki H; Tsuji T; Mawatari K; Shimada K
J Cardiol; 2001 Dec; 38(6):327-35. PubMed ID: 11806090
[TBL] [Abstract][Full Text] [Related]
20. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
